about
Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorderNon-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.The positive effect on ketamine as a priming adjuvant in antidepressant treatment.New frontiers in the neuropsychopharmacology of mental illness.Dysregulation of the hypothalamus-pituitary-adrenal axis predicts some aspects of the behavioral response to chronic fluoxetine: association with hippocampal cell proliferation.Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Role of peripheral vascular resistance for the association between major depression and cardiovascular disease.The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver.Gene expression and proliferation biomarkers for antidepressant treatment resistance.CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.Treatment-resistant depression: are animal models of depression fit for purpose?Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.Murine Depression Model and its Potential Applications for Discovering Foods and Farm Products with Antidepressant-Like Effects.Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depressionSignificant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment.Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder.Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression.Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients.Nanomedicine applications in women's health: state of the art.
P2860
Q26823991-03BD976A-AA79-41A8-8B9B-015D23194243Q30370894-905AF63B-02AE-471C-99FA-3211FA69BFC6Q30408646-9EB0C849-3B34-4DEB-AF8A-CCFFC8E32DCEQ34198001-EE431F2B-CF37-4D88-B5B9-8E33D70A461DQ34265505-317EF386-A62C-4FB1-A889-4F680E73629AQ34556039-BD737B72-A175-4BDF-A959-4F59A17A8CBEQ35558259-1BCB02F7-200A-454F-802F-C7A343878E94Q37099353-CC1ADED8-BD15-4628-8B25-7986AB6C3607Q38432665-4F1922DD-45E1-4C68-8DCF-6DDBE79EA41FQ38444087-346E1AE4-6270-45CE-B40A-7DD758019EAFQ38569708-8143DE62-7AAE-4B55-B402-1F9B8EFF46E7Q38635337-3F476D2E-F561-47DA-808D-DB892E458CCCQ38684363-3C687DF3-4B08-405A-9F28-4B21C6A73529Q41270351-36991E55-C52A-46D2-9C6B-2BA94EF7FE1CQ42730588-F203426E-6C81-49D1-82BF-231213259305Q47140935-51314315-F144-45CB-B0C6-D00478351B3EQ47698260-180C60F4-BFD4-471A-9C9A-CBA9D41CDB8CQ48064738-43596B44-BC4D-4F48-AF6A-88B88AC35EE1Q48075957-B6B90986-43BB-4902-BC82-65B8435B70B7Q48086902-415FB098-F499-4BD2-990D-5D180126466BQ48244608-777D8864-DE01-4E4B-BF51-D626FD33068AQ55091399-3A7BCBBE-45A1-470C-AB0F-D218F7F32158
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Mechanisms of antidepressant resistance
@en
Mechanisms of antidepressant resistance.
@nl
type
label
Mechanisms of antidepressant resistance
@en
Mechanisms of antidepressant resistance.
@nl
prefLabel
Mechanisms of antidepressant resistance
@en
Mechanisms of antidepressant resistance.
@nl
P2860
P50
P356
P1476
Mechanisms of antidepressant resistance
@en
P2860
P356
10.3389/FPHAR.2013.00146
P577
2013-11-22T00:00:00Z